Clinical Trial Update: A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function [Phase 1]

View source ↗

Summary

Phase 1 study assessing blood levels, safety, and tolerability of PF-00734200 in subjects with impaired kidney function and in those with normal kidney function…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• PF-00734200

Snippet

Sponsor: Pfizer | Conditions: Renal Insufficiency, Chronic | Phase 1 | Status: COMPLETED